diflunisal has been researched along with Leukemia, Myeloid, Acute in 1 studies
Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.
Leukemia, Myeloid, Acute: Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shirakawa, K | 1 |
Wang, L | 1 |
Man, N | 1 |
Maksimoska, J | 1 |
Sorum, AW | 1 |
Lim, HW | 1 |
Lee, IS | 1 |
Shimazu, T | 1 |
Newman, JC | 1 |
Schröder, S | 1 |
Ott, M | 1 |
Marmorstein, R | 1 |
Meier, J | 1 |
Nimer, S | 1 |
Verdin, E | 1 |
1 other study available for diflunisal and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Doma | 2016 |